During the past decade, MHAT ''Sveta Petka" AD conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT ''Sveta Petka" AD" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MHAT ''Sveta Petka" AD" are "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "MHAT ''Sveta Petka" AD" in a lesser frequency.

Most popular intervention types in "MHAT ''Sveta Petka" AD" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (3 trials), "Clostridium difficile vaccine" (1 trials), "PTM filgotinib" (1 trials) and "Placebo to match filgotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT ''Sveta Petka" AD" are 5 trials for "All" genders.

Currently, there are NaN active trials in "MHAT ''Sveta Petka" AD". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in MHAT ''Sveta Petka" AD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MHAT ''Sveta Petka" AD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".